Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Infused Autograft-Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B-Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched-Control Study

Edwin Burgstaler, Luis F. Porrata, MD, Jeffrey L. Winters, MD, Eapen K. Jacob, MD, David J. Inwards, MD, Stephen M. Ansell, MD PhD, Ivana Micallef, MD, Patrick B. Johnston, Jose C Villasboas, MD, Jonas Paludo, MD, Svetomir N. Markovic, MD PhD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-133854

Published: 2020

Journal Articles

Hypomagnesemia Is Associated with an Increased Risk of Failure in Patients Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation

Jennifer Gile, MD, Camden Lopez, MS, Gordon Ruan, MD, Matthew A Hathcock, Jithma P. Abeykoon, MD, M Molly McMahon, MD, Jose C Villasboas, MD, Luis F. Porrata, MD, Stephen M. Ansell, MD PhD, William J Hogan, MB, BCh, Thomas E. Witzig, MD

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-140474

Published: 2020

Journal Articles

Central Nervous System (CNS) Involvement of Richter Transformation: A Single Center Experience

Yucai Wang, MDPhD, Marcella Tschautscher, MD, Sameer A. Parikh, MD, Timothy G. Call, MD, Neil E. Kay, MD, Patrick B. Johnston, Luis F. Porrata, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD, Stephen M. Ansell, MD PhD, Min Shi, MDPhD, Saad S. Kenderian, MB, ChB, Eli Muchtar, MD, Suzanne R. Hayman, MD, Amber B. Koehler, PA-C, MS, Jose F. Leis, MD PhD, Wei Ding, MD PhD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-139769

Published: 2020

Journal Articles

Lenalidomide/RCHOP (R2CHOP) Produces High Response Rates and Overall Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma- Results from MC078E

Sanjal H Desai, MD, Betsy Laplant, MS, William R. Macon, MD, Rebecca L. King, MD, Yucai Wang, MDPhD, David J. Inwards, MD, Ivana Micallef, MD, Patrick B. Johnston, Luis F. Porrata, MD, Stephen M. Ansell, MD PhD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-141298

Published: 2020

Journal Articles

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

Arushi Khurana, MBBS, Matthew A Hathcock, Thomas M. Habermann, MD, Abdullah S. Al Saleh, MBBS, Sangeetha Gandhi, MBBS, Tuan A Truong, Nabila Bennani, MD, Jonas Paludo, MD, Jose C Villasboas, MD, Stephen M. Ansell, MD PhD, David J. Inwards, MD, Luis F. Porrata, MD, Patrick B. Johnston, Ivana Micallef, MD, Yi Lin, MD PhD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142511

Published: 2020

Journal Articles

Impact of Cell of Origin (COO) on Long Term Outcomes Post Autologous Hematopoietic Cell Transplant in Patients with Relapsed/ Refractory Chemotherapy Sensitive De-Novo Diffuse Large B-Cell Lymphoma (DLBCL)

Madiha Iqbal, MBBS, Yennifer Gil, Jonas Paludo, MD, Allison C. Rosenthal, D.O., Zhou Li, MS, Manuel Beltran, David J. Inwards, MD, Luis F. Porrata, MD, Ivana Micallef, MD, Jose C Villasboas, MD, Patrick B. Johnston, Stephen M. Ansell, MD PhD, Craig B. Reeder, MD, Hemant S. Murthy, MD, Vivek Roy, MD, James M. Foran, MD, Han W. Tun, MD, Mohamed A. Kharfan-Dabaja, MDMBA, Ernesto Ayala, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-136332

Published: 2020

Journal Articles

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory (IMiD) Drug Lenalidomide Produces Durable Responses in Patients with Heavily Pretreated Relapsed Lymphoma

Brenda Ernst, MD, Amylou Constance Dueck, PhD, Angela Toro, NP, Patrick B. Johnston, MD PhD, Thomas Haberman, MD, Jose F. Leis, MD PhD, Joseph R. Mikhael, MD, Grzegorz S. Nowakowski, MD, Joseph P. Colgan, MD, Luis F. Porrata, MD, James L Slack, MD, Stephen M. Ansell, MD PhD, Thomas E. Witzig, MD, Craig B. Reeder, MD

Blood (2014) 124 (21): 3100.

https://doi.org/10.1182/blood.V124.21.3100.3100

Published: 2014

Journal Articles

IL-10 Contributes to the Development of Immunosuppressive CD14+HLA-DR low/- monocytes in B-Cell Non-Hodgkin’s Lymphoma

Bing Xiu, MD PhD, Yi Lin, MD PhD, Deanna Grote, BA, Steven Ziesmer, Michael Gustafson, PhD, Mary Maas, Zhe Zhang, PhD, Allan B Dietz, PhD, Aibin Liang, MD PhD, Luis F. Porrata, MD, Anne J. Novak, PhD, Zhi-Zhang Yang, MD, Stephen M. Ansell, MD PhD

Blood (2014) 124 (21): 2979.

https://doi.org/10.1182/blood.V124.21.2979.2979

Published: 2014

Journal Articles

Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Classical Hodgkin Lymphoma

Luis F. Porrata, MD, David J. Inwards, MD, Stephen M. Ansell, MD PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD PhD, William Hogan, MD, Svetomir N. Markovic, MD, PhD

Blood (2014) 124 (21): 1189.

https://doi.org/10.1182/blood.V124.21.1189.1189

Published: 2014

Journal Articles

Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress

Blood (2014) 124 (21): 4474.

https://doi.org/10.1182/blood.V124.21.4474.4474

Published: 2014

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During RCHOP Treatment Cycles Predicts Clinical Outcomes In Diffuse Large B-Cell Lymphoma

Luis F. Porrata, MD, Kay M. Ristow, Thomas M Habermann, MD, Thomas E Witzig, MD, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M Ansell, M.D. Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2013) 122 (21): 4306.

https://doi.org/10.1182/blood.V122.21.4306.4306

Published: 2013

Journal Articles

A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results

Blood (2013) 122 (21): 4352.

https://doi.org/10.1182/blood.V122.21.4352.4352

Published: 2013

Journal Articles

A Phase I/II Combination Of RAD001 (Everolimus) and Lenalidomide For Relapsed Lymphoid Malignancy: Phase I Results

Craig Reeder, MD, Amylou Constance Dueck, PhD, Katherine Gano, Craig Nichols, Angela Toro, NP, Daniel Johnson, Patrick B. Johnston, Thomas M. Habermann, Jose F Leis, MD, PhD, Grzegorz S. Nowakowski, MD, Joseph Mikhael, MD, Joseph Colgan, Luis F. Porrata, MD, James L Slack, MD, Stephen M Ansell, Thomas E Witzig

Blood (2013) 122 (21): 4350.

https://doi.org/10.1182/blood.V122.21.4350.4350

Published: 2013

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During ABVD Treatment Cycles Predicts Clinical Outcomes in Classical Hodgkin Lymphoma (HL).

Luis F. Porrata, MD, Kay M. Ristow, Thomas M Habermann, MD, Thomas E. Witzig, MD, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M Ansell, M.D., Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2012) 120 (21): 2634.

https://doi.org/10.1182/blood.V120.21.2634.2634

Published: 2012

Journal Articles

Lack of Prognostic Significance of Monosomal Karyotype and Absolute Lymphocyte Count At Diagnosis in Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

Saad J. Sirop, MD, Aref Al-Kali, MD, Kebede Begna, MD, Naseema Gangat, MD, Louis Letendre, MD, Luis F. Porrata, MD, William J Hogan, MD, Mark R Litzow, MD, Mrinal M. Patnaik, MBBS, MD

Blood (2012) 120 (21): 1476.

https://doi.org/10.1182/blood.V120.21.1476.1476

Published: 2012

Journal Articles

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Saad J. Sirop, MD, Thomas M Habermann, MD, William R Macon, MD, Kay M. Ristow, Stephen M Ansell, MD, PhD, Joseph P Colgan, MD, Patrick B. Johnston, MD, PhD, David J. Inwards, MD, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Carrie Thompson, MD, Luis F. Porrata, MD, James A. Martenson, Jr., MD, James R Cerhan, MD, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2012) 120 (21): 1525.

https://doi.org/10.1182/blood.V120.21.1525.1525

Published: 2012

Journal Articles

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Interim Positron-Emission Tomography in Predicting Progression-Free Survival and Time to Progression in Classical Hodgkin Lymphoma (HL)

Luis F. Porrata, MD, Kay M. Ristow, Thomas M. Habermann, Thomas E Witzig, Joseph P. Colgan, MD, David J. Inwards, MD, Stephen M. Ansell, M.D., Ph.D., Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2012) 120 (21): 1527.

https://doi.org/10.1182/blood.V120.21.1527.1527

Published: 2012

Journal Articles

Combination of Lenalidomide with R-CHOP (R2CHOP) Is Well-Tolerated and Effective As Initial Therapy for Aggressive B-Cell Lymphomas - A Phase II Study

Grzegorz S. Nowakowski, MD, Betsy R. LaPlant, Craig Reeder, MD, James M. Foran, MD, FRCPC, Luis F. Porrata, MD, William R Macon, MD, Patrick B. Johnston, MD, PhD, Candido E. Rivera, MD, Thomas M Habermann, MD, David J. Inwards, MD, Ivana N. Micallef, MD, Garth D Nelson, Stephen M. Ansell, M.D., Ph.D., Thomas E. Witzig, MD

Blood (2012) 120 (21): 689.

https://doi.org/10.1182/blood.V120.21.689.689

Published: 2012

Journal Articles

Patients with Immunoglobulin Light Chain Amyloidosis (AL) Undergoing High Dose Chemotherapy with Autologous Stem Cell Transplantation (ASCT) have Superior Outcomes As Compared to Patients with Multiple Myeloma (MM)

Kirupananthan Seenithamby, Angela Dispenzieri, MD, Martha Q Lacy, MD, Shaji K. Kumar, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., Mark R Litzow, MD, Dennis A. Gastineau, MD, David J. Inwards, MD, Ivana N. Micallef, MD, Stephen M. Ansell, M.D., Ph.D., Patrick B. Johnston, MD, PhD, Luis F. Porrata, MD, Mrinal M. Patnaik, MBBS, MD, William J Hogan, MBBCh, Morie Abraham A Gertz, MD

Blood (2012) 120 (21): 600.

https://doi.org/10.1182/blood.V120.21.600.600

Published: 2012

Journal Articles

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Luis F. Porrata, MD, Kay M. Ristow, Joseph P. Colgan, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, David James Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Svetomir N. Markovic, MD, PhD

Blood (2011) 118 (21): 3642.

https://doi.org/10.1182/blood.V118.21.3642.3642

Published: 2011

NARROW

Infused Autograft-Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B-Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched-Control Study

Hypomagnesemia Is Associated with an Increased Risk of Failure in Patients Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation

Central Nervous System (CNS) Involvement of Richter Transformation: A Single Center Experience

Lenalidomide/RCHOP (R2CHOP) Produces High Response Rates and Overall Survival in New, Untreated Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma- Results from MC078E

Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin's Lymphoma (NHL)

Impact of Cell of Origin (COO) on Long Term Outcomes Post Autologous Hematopoietic Cell Transplant in Patients with Relapsed/ Refractory Chemotherapy Sensitive De-Novo Diffuse Large B-Cell Lymphoma (DLBCL)

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory (IMiD) Drug Lenalidomide Produces Durable Responses in Patients with Heavily Pretreated Relapsed Lymphoma

IL-10 Contributes to the Development of Immunosuppressive CD14+HLA-DR low/- monocytes in B-Cell Non-Hodgkin’s Lymphoma

Infused Autograft Lymphocyte to Monocyte Ratio and Survival in Classical Hodgkin Lymphoma

Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During RCHOP Treatment Cycles Predicts Clinical Outcomes In Diffuse Large B-Cell Lymphoma

A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results

A Phase I/II Combination Of RAD001 (Everolimus) and Lenalidomide For Relapsed Lymphoid Malignancy: Phase I Results

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio Recovery During ABVD Treatment Cycles Predicts Clinical Outcomes in Classical Hodgkin Lymphoma (HL).

Lack of Prognostic Significance of Monosomal Karyotype and Absolute Lymphocyte Count At Diagnosis in Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Peripheral Blood Absolute Lymphocyte/Monocyte Ratio At Diagnosis Is Independent of the Interim Positron-Emission Tomography in Predicting Progression-Free Survival and Time to Progression in Classical Hodgkin Lymphoma (HL)

Combination of Lenalidomide with R-CHOP (R2CHOP) Is Well-Tolerated and Effective As Initial Therapy for Aggressive B-Cell Lymphomas - A Phase II Study

Patients with Immunoglobulin Light Chain Amyloidosis (AL) Undergoing High Dose Chemotherapy with Autologous Stem Cell Transplantation (ASCT) have Superior Outcomes As Compared to Patients with Multiple Myeloma (MM)

Peripheral Blood Lymphocyte/Monocyte Ratio At Diagnosis and Survival in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only